Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
High-Grade Upper Tract Urothelial Carcinoma
and you are
between 18 and 80
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to see if getting chemotherapy with Gemcitabine and Cisplatin (GC) for 2-4 cycles can help shrink the tumor before undergoing surgery and improves the overall survival for high-grade upper tract urothelial carcinoma.

Provided treatments

  • Procedure: Radical nephroureterectomy
  • Procedure: Distal ureterectomy
  • Drug: Neoadjuvant Chemotherapy
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02876861. The sponsor of the trial is Xiangya Hospital of Central South University and it is looking for 50 volunteers for the current phase.
Official trial title:
Neoadjuvant Chemotherapy Versus Surgery Alone in Patients With High-Grade Upper Tract Urothelial Carcinoma